Gladstone scientist Skyler Blume (IMAGE)
Caption
Researchers at Gladstone Institutes develop a drug that mimics the cellular effects of low-oxygen therapy for the treatment of inherited mitochondrial diseases. Seen here is Skyler Blume, first author of the new study.
Credit
Photo: Michael Short/Gladstone Institutes
Usage Restrictions
Use for non-commercial purposes only, in relation to this study
License
Original content